Replacing Finger Stick? DexCom Says Its Latest CGM Data Is A Key Step
This article was originally published in The Gray Sheet
Continuous glucose monitor firm DexCom has defined 10 percent accuracy compared to a lab reference as the crucial target to support its monitors as outright replacements for patient self-monitoring to inform insulin dosing. It has now met that goal in an initial study, but pivotal data will be needed to convince FDA.